DOCSLIB.ORG

Infection What Is the Clinical Significance of Positive Blood

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Infection What Is the Clinical Significance of Positive Blood Bone Marrow Transplantation (2005) 35, 303–306 & 2005 Nature Publishing Group All rights reserved 0268-3369/05 $30.00 www.nature.com/bmt Infection What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience E Simoneau1, M Kelly1, AC Labbe1, J Roy2 and M Laverdie` re1 1Department of Microbiology-Infectious Diseases, Hoˆpital Maisonneuve-Rosemont, Quebec, Canada; and 2Department of Hematology, Hoˆpital Maisonneuve-Rosemont, Quebec, Canada Summary: underlying predisposing condition to invasive aspergil- losis.3 To our knowledge, no study has yet examined the Hematopoietic stem cell (HSC) transplantation is the significance of positive blood cultures with Aspergillus sp most frequent underlying predisposing condition to in this very high-risk population of patients. We report a invasive aspergillosis. However, the significance of posi- 23-year single-center retrospective study of positive blood tive blood culture with Aspergillus sp in this particular cultures for Aspergillus sp documented in HSC transplant population remains uncertain. We retrospectively re- recipients. viewed all blood cultures performed in 1453 patients who received HSC transplant at our institution between 1980 and 2002. We identified 19 patients with positive blood Patients and methods cultures with Aspergillus sp. Only one of these patients had clinical, histologic or microbiologic evidence of Blood culture records of all patients who underwent an invasive aspergillosis. Thus, even in a population at HSC transplantation at Hoˆ pital Maisonneuve-Rosemont highest risk for invasive aspergillosis, positive blood (HMR) between April 1980 and December 2002 were cultures with Aspergillus sp remain unusual, and cannot reviewed. Over this period, three different blood culture be readily associated with invasive aspergillosis. A case by systems have been sequentially used in our microbiology case assessment by treating physicians of the clinical and laboratory: a conventional broth manual system from radiologic parameters should be systematically made to 1980 to 1985, a lysis centrifugation blood culture system establish the significance of aspergillemia. Single bottle (Isolatort system) from 1985 to 1996, and an automated positivity, obtained with the lysis-centrifugation blood blood culture system (BacT/Alertt system) thereafter. culture system, is a common indicator of pseudoaspergil- Medical records of recipients with Aspergillus sp positive lemia. blood cultures were reviewed to determine the clinical Bone Marrow Transplantation (2005) 35, 303–306. significance of these positive blood cultures. Aspergillus sp doi:10.1038/sj.bmt.1704793 fungemia was classified as definite, probable or pseudo- Published online 6 December 2004 fungemia according to previously proposed criteria.4 Keywords: Aspergillus; hematopoietic stem cell (HSC) Definite Aspergillus sp fungemia was defined as the transplantation; bloodstream infections; aspergillemia presence of Aspergillus sp in blood plus histologic or microbiologic evidence of Aspergillus sp in infected tissue; probable aspergillemia was defined as the presence of The significance of positive blood cultures with Aspergillus Aspergillus sp in blood with clinical signs and symptoms sp varies according to the patient population. In a single- compatible with disseminated aspergillosis, but no histo- cancer center study, positive blood cultures with Aspergillus pathologic evidence of invasive aspergillosis and pseudo- sp represented pseudofungemia in all 12 patients with solid fungemia was defined as the presence of Aspergillus sp in tumors, whereas definite or probable aspergillemia was blood without compatible signs and symptoms, imaging, observed in 12 of 24 patients with hematological malig- culture, or histologic evidence of invasive aspergillosis. nancies.1 In patients with deep-seated pulmonary aspergil- losis, true aspergillemia was observed in 10.1% of 89 patients.2 HSC transplantation is the most important Results From April 1980 to December 2002, 1453 patients were transplanted at HMR. A total of 939 different episodes of Correspondence: Dr M Laverdie` re, Department of Microbiology- bloodstream infections in 525 (36%) recipients were Infectious Diseases, Hoˆ pital Maisonneuve-Rosemont, 5415 Boul de documented. Of these 525 patients, 377 were allogeneic L’Assomption Montreal, Quebec, Canada H1T 2M4; E-mail: [email protected] and 148 autologous transplant. Aspergillemia was observed Received 14 June 2004; accepted 11 October 2004 23 times in 21 patients. Patients 1 and 10 each had two Published online 6 December 2004 separate episodes at 3- and 2-month intervals, respectively Bone Marrow Transplantation 304 Table 1 Clinical characteristics and significance of positive blood cultures with Aspergillus sp in 19 HSCT recipients Patient Date Age Sex Underlying HSCT Neutropenia GVHD Duration of Days after Fever Anti- Evidence of Species no (months/ (years) haematologic type on day of and/or HD neutropenia HSCT at at time of aspergillusantifungal clinical years) diagnosis positive steroids following time of aspergillemia at time of aspergillosis blood culture HSCT (days) aspergillemia sampling Significance of aspergillemia in HSCT recipients 1a 06/88 5 F ALL Allo NA Yes NA 10 NA No No A fumigatus 1b 09/88 5 F ALL Allo NA Yes NA 91 NA No No A fumigatus 2 03/89 16 M ALL Allo No No 21 55 No No No A niger 3 05/89 18 M ALL Auto No Yes 28 29 No No No Aspergillus sp 4 05/90 39 F MM Allo Yes Yes 25 4 Yes No No A fumigatus 5 12/90 49 M NHL Auto Yes Yes 13 4 No No No Aspergillus sp 6 12/91 42 F NHL Auto Yes Yes 105 10 Yes Yes No A fumigatus 7 06/92 39 F CML Allo NA Yes NA 77 NA Yes No A fumigatus 8 08/92 32 F AML Allo Yes Yes 19 6 Yes No No Aspergillus sp E Simoneau 9 09/92 30 F ALL Allo Yes No 20 4 No No No A fumigatus 10a 10/92 3 F AA Auto No Yes NA 41 No No No A fumigatus 10b 12/92 3 F AA Auto No Yes NA 101 No No No A fumigatus et al 11 11/92 7 M IMM Allo No Yes 14 54 No No No Aspergillus sp 12 11/92 47 M NHL Auto No Yes 26 31 No Yes No A niger 13 04/94 58 M NHL Auto Yes Yes 21 4 Yes No No A fumigatus 14 05/94 12 F CML Allo Yes Yes 28 11 No No No A fumigatus 15 03/95 3 F MDS Allo No Yes 24 135 No No No Aspergillus sp 16 03/95 3 F AA Allo Yes Yes 32 13 No Yes No Aspergillus sp 17 06/95 36 F CML Allo No Yes 16 537 Yes No No A fumigatus 18 09/96 52 M CML Allo No Yes 19 101 Yes Yes Yes Aspergillus sp 19 10/97 41 M CML Allo Yes Yes 28 29 No Yes No A fumigatus HSCT ¼ hematopoietic stem cell transplantation; AA ¼ aplastic anemia; ALL ¼ acute lymphocytic leukemia; AML ¼ acute myeloblastic leukemia; MM ¼ multiple myeloma; CML ¼ chronic myelogenic leukemia; NHL ¼ non-Hodgkin’s lymphoma; MDS ¼ myelodysplasic syndrome; IMM ¼ primary immune deficiency; Allo ¼ allogeneic; Auto ¼ autologous; GVHD ¼ graft versus host disease; HD steroids ¼ High-dose steroids; NA: not available. Significance of aspergillemia in HSCT recipients E Simoneau et al 305 (Table 1). Median time between the HSC transplantation were processed in a laminar air-flow facility, an airborne and positive blood culture with Aspergillus sp was 29 days contamination likely could not be completely avoided. (range 4–537 days). Aspergillus sp was recovered from a Automated blood culture systems are now commonly used single bottle collected in different sets of blood cultures for in hospital microbiology laboratories. The adequacy of all patients. All aspergillemic episodes were observed these systems to recover fungal pathogens from blood during the period when the lysis centrifugation blood cultures has been questioned, and the superiority of the culture system was used. Aspergillus fumigatus was lysis–centrifugation blood culture system has been under- identified in 11 patients, Aspergillus niger in two patients lined.5 However, routine procurement of blood cultures and nonspeciated Aspergillus in eight patients. Medical with the latter system in febrile neutropenic patients with records of 19 recipients were available for review. Six acute leukemia has shown no advantage over an automated patients were on Amphotericin B prophylaxis or treatment system to detect fungal and bacterial blood pathogens, and at the time of their blood sampling (Table 1). No other has been associated with high degree of contamination.6 anti-aspergillus antifungal drugs were used in any of our Large studies have been conducted with modern automated patients. Only two patients (patient 17 and 18) died within blood culture systems, but recovery of Aspergillus sp is not 30 days following their aspergillemia. Patient 17 had a documented.7–10 We have experimentally inoculated as little broncho-pulmonary-obliterans pneumonitis and an intest- as one to 10 conidia into blood culture bottles of our inal graft-versus-host-disease (GVHD) with severe electro- current colorimetric automated blood culture system lytic disorders. She died 10 days after her single positive (BacT/Alertt), and systematically detected growth after blood culture bottle with Aspergillus. A post-mortem only 24 h of incubation, hence establishing the ability of the examination revealed diffuse multiorgan lymphomatous system to support and detect the growth of Aspergillus sp. infiltrations with no signs of aspergillosis. Patient 18 had Vascular invasion characterizes invasive aspergillosis. compatible pulmonary infiltrates with clinical signs and Aspergillus hyphae are endocytosed by the blood vessel symptoms and evolution suggestive of a probable invasive endothelial cells causing progressive endothelial cell injury aspergillosis. Despite systemic antifungal therapy, this and thrombosis. Vascular endothelial cells exposed in vitro patient suffering from chronic GVHD died 10 days later. to killed Aspergillus hyphae continue to cause cell injury An autopsy was not granted. Of the remaining 17 patients, and invasion.11 It is likely that the viability of the only four received Amphotericin B, mostly for persisting endocytosed Aspergillus hyphae is considerably impaired, febrile neutropenia, during 5–19 days following the positive which therefore reduces the potential to recover them blood culture with Aspergillus.
Load more

Recommended publications
  • Fungal Infections from Human and Animal Contact
    Journal of Patient-Centered Research and Reviews Volume 4 Issue 2 Article 4 4-25-2017 Fungal Infections From Human and Animal Contact Dennis J. Baumgardner Follow this and additional works at: https://aurora.org/jpcrr Part of the Bacterial Infections and Mycoses Commons, Infectious Disease Commons, and the Skin and Connective Tissue Diseases Commons Recommended Citation Baumgardner DJ. Fungal infections from human and animal contact. J Patient Cent Res Rev. 2017;4:78-89. doi: 10.17294/2330-0698.1418 Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes, and the patient experience. REVIEW Fungal Infections From Human and Animal Contact Dennis J. Baumgardner, MD Aurora University of Wisconsin Medical Group, Aurora Health Care, Milwaukee, WI; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI; Center for Urban Population Health, Milwaukee, WI Abstract Fungal infections in humans resulting from human or animal contact are relatively uncommon, but they include a significant proportion of dermatophyte infections. Some of the most commonly encountered diseases of the integument are dermatomycoses. Human or animal contact may be the source of all types of tinea infections, occasional candidal infections, and some other types of superficial or deep fungal infections. This narrative review focuses on the epidemiology, clinical features, diagnosis and treatment of anthropophilic dermatophyte infections primarily found in North America.
    [Show full text]
  • Candida Auris
    microorganisms Review Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities Suhail Ahmad * and Wadha Alfouzan Department of Microbiology, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat 13110, Kuwait; [email protected] * Correspondence: [email protected]; Tel.: +965-2463-6503 Abstract: Candida auris, a recently recognized, often multidrug-resistant yeast, has become a sig- nificant fungal pathogen due to its ability to cause invasive infections and outbreaks in healthcare facilities which have been difficult to control and treat. The extraordinary abilities of C. auris to easily contaminate the environment around colonized patients and persist for long periods have recently re- sulted in major outbreaks in many countries. C. auris resists elimination by robust cleaning and other decontamination procedures, likely due to the formation of ‘dry’ biofilms. Susceptible hospitalized patients, particularly those with multiple comorbidities in intensive care settings, acquire C. auris rather easily from close contact with C. auris-infected patients, their environment, or the equipment used on colonized patients, often with fatal consequences. This review highlights the lessons learned from recent studies on the epidemiology, diagnosis, pathogenesis, susceptibility, and molecular basis of resistance to antifungal drugs and infection control measures to combat the spread of C. auris Citation: Ahmad, S.; Alfouzan, W. Candida auris: Epidemiology, infections in healthcare facilities. Particular emphasis is given to interventions aiming to prevent new Diagnosis, Pathogenesis, Antifungal infections in healthcare facilities, including the screening of susceptible patients for colonization; the Susceptibility, and Infection Control cleaning and decontamination of the environment, equipment, and colonized patients; and successful Measures to Combat the Spread of approaches to identify and treat infected patients, particularly during outbreaks.
    [Show full text]
  • Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting
    Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting a b,c, Alexander Lepak, MD , David Andes, MD * KEYWORDS Invasive candidiasis Pharmacokinetics-pharmacodynamics Therapy Source control Invasive fungal infections (IFI) and fungal sepsis in the intensive care unit (ICU) are increasing and are associated with considerable morbidity and mortality. In this setting, IFI are predominantly caused by Candida species. Currently, candidemia represents the fourth most common health care–associated blood stream infection.1–3 With increasingly immunocompromised patient populations, other fungal species such as Aspergillus species, Pneumocystis jiroveci, Cryptococcus, Zygomycetes, Fusarium species, and Scedosporium species have emerged.4–9 However, this review focuses on invasive candidiasis (IC). Multiple retrospective studies have examined the crude mortality in patients with candidemia and identified rates ranging from 46% to 75%.3 In many instances, this is partly caused by severe underlying comorbidities. Carefully matched, retrospective cohort studies have been undertaken to estimate mortality attributable to candidemia and report rates ranging from 10% to 49%.10–15 Resource use associated with this infection is also significant. Estimates from numerous studies suggest the added hospital cost is as much as $40,000 per case.10–12,16–20 Overall attributable costs are difficult to calculate with precision, but have been estimated to be close to 1 billion dollars in the United States annually.21 a University of Wisconsin, MFCB, Room 5218, 1685 Highland Avenue, Madison, WI 53705-2281, USA b Department of Medicine, University of Wisconsin, MFCB, Room 5211, 1685 Highland Avenue, Madison, WI 53705-2281, USA c Department of Microbiology and Immunology, University of Wisconsin, MFCB, Room 5211, 1685 Highland Avenue, Madison, WI 53705-2281, USA * Corresponding author.
    [Show full text]
  • Candida Auris Fungemia at Tified
    RESEARCH LETTERS This case illustrates the need to better define the geo- Management of Patients with graphic extent and modes of transmission of this debilitat- ing disease so that primary control measures can be iden- Candida auris Fungemia at tified. In addition, health workers must be provided with Community Hospital, the training and tools to diagnose and treat M. ulcerans. Brooklyn, New York, Research into a point-of-care diagnostic test is needed so 1 that timely treatment can minimize disability and costs to USA, 2016–2018 the family. Jenny YeiSol Park,2 Nicole Bradley,3 Acknowledgments Steven Brooks, Sibte Burney, Chanie Wassner Thanks to Emily Duecke, Sidy Ba, Carlos Bleck, and Teunella Wolters for their sharp clinical skills and therapeutic efforts on DOI: https://doi.org/10.3201/eid2503.180927 behalf of this patient. Candida auris is an emerging fungus that can cause inva- sive infections. It is associated with high mortality rates and About the Author resistance to multiple classes of antifungal drugs and is dif- Ms. Turner is a family nurse practitioner living and working in ficult to identify with standard laboratory methods. We de- Dakar, Senegal. Her background includes trauma and pediatric scribe the management and outcomes of 9 patients with C. primary care in high-income and low-income countries. auris fungemia in Brooklyn, New York, USA. References andida auris is an emerging fungus that can cause inva- 1. Sakyi SA, Aboagye SY, Otchere ID, Yeboah-Manu D. Clinical and Csive infections associated with high mortality rates and laboratory diagnosis of Buruli ulcer disease: a systematic review.
    [Show full text]
  • Fever, Rash and Fungemia in a Traveler from South China Osamuyimen Igbinosa*, Krishna Dass and Glenn Wortmann
    ical C lin as C e f R o Igbinosa et al., J Clin Case Rep 2015, 5:11 l e a p n o r r DOI: 10.4172/2165-7920.1000639 t u s o J Journal of Clinical Case Reports ISSN: 2165-7920 Case Report Open Access Fever, Rash and Fungemia in a Traveler from South China Osamuyimen Igbinosa*, Krishna Dass and Glenn Wortmann Section of Infectious Diseases, Medstar Washington Hospital Center, Washington DC, USA Abstract Introduction: Penicillium (Talaromyces) marneffei is a dimorphic fungus that is endemic in Southeast Asia and South China, but rarely seen the United States except in immunosuppressed patients who have had travel-related exposure. Case Presentation: A 28 year-old man with advanced HIV/AIDS presented with dyspnea, cough and fever two weeks after returning from Shenzhen, South China. He was treated for presumptive Pneumocystis jiroveci pneumonia with improvement in his symptoms and was then started on antiretroviral therapy. Three weeks later he developed rash and fever, and blood culture grew Penicillium (Talaromyces) marneffei. Conclusion: This case highlights the importance of obtaining a detailed travel history in order to incorporate travel-related diseases in a differential diagnosis. Keywords: HIV/AIDS; Anti-retroviral therapy; Pneumocystis jiroveci A chest x-ray demonstrated bilateral pulmonary infiltrates compatible pneumonia with Pneumocystis jiroveci pneumonia (PJP). Sputum stained for acid-fast bacilli was negative three times, and the patient refused Abbreviations: ART: Antiretroviral Therapy; PJP: Pneumocystis bronchoscopy. He was treated for presumptive PJP with trimethoprim/ jiroveci pneumonia; MALDI- TOF: Matrix-Assisted Laser Desorption/ sulfamethoxazole, with improvement in his dyspnea.
    [Show full text]
  • Fungal-Bacterial Interactions in Health and Disease
    pathogens Review Fungal-Bacterial Interactions in Health and Disease 1, 1, 1,2 1,2,3 Wibke Krüger y, Sarah Vielreicher y, Mario Kapitan , Ilse D. Jacobsen and Maria Joanna Niemiec 1,2,* 1 Leibniz Institute for Natural Product Research and Infection Biology—Hans Knöll Institute, Jena 07745, Germany; [email protected] (W.K.); [email protected] (S.V.); [email protected] (M.K.); [email protected] (I.D.J.) 2 Center for Sepsis Control and Care, Jena 07747, Germany 3 Institute of Microbiology, Friedrich Schiller University, Jena 07743, Germany * Correspondence: [email protected]; Tel.: +49-3641-532-1454 These authors contributed equally to this work. y Received: 22 February 2019; Accepted: 16 May 2019; Published: 21 May 2019 Abstract: Fungi and bacteria encounter each other in various niches of the human body. There, they interact directly with one another or indirectly via the host response. In both cases, interactions can affect host health and disease. In the present review, we summarized current knowledge on fungal-bacterial interactions during their commensal and pathogenic lifestyle. We focus on distinct mucosal niches: the oral cavity, lung, gut, and vagina. In addition, we describe interactions during bloodstream and wound infections and the possible consequences for the human host. Keywords: mycobiome; microbiome; cross-kingdom interactions; polymicrobial; commensals; synergism; antagonism; mixed infections 1. Introduction 1.1. Origins of Microbiota Research Fungi and bacteria are found on all mucosal epithelial surfaces of the human body. After their discovery in the 19th century, for a long time the presence of microbes was thought to be associated mostly with disease.
    [Show full text]
  • WOS000311017000004.Pdf
    Microbes and Infection 14 (2012) 1144e1151 www.elsevier.com/locate/micinf Original article Dermatophyteehost relationship of a murine model of experimental invasive dermatophytosis James Venturini a,b, Anuska Marcelino A´ lvares c, Marcela Rodrigues de Camargo a,b, Camila Martins Marchetti a, Thais Fernanda de Campos Fraga-Silva a, Ana Carolina Luchini d, Maria Sueli Parreira de Arruda a,* a Faculdade de Cieˆncias, UNESP e Univ Estadual Paulista, Departamento de Cieˆncias Biolo´gicas, Laborato´rio de Imunopatologia Experimental, Av. Eng. Luiz Edmundo C. Coube 14-01, 17033-360 Bauru, SP, Brazil b Faculdade de Medicina de Botucatu, UNESP e Univ Estadual Paulista, Distrito de Rubia˜o Junior s/n, 18618-970 Botucatu, SP, Brazil c Departamento de Microbiologia, Imunologia e Parasitologia, UNIFESP e Universidade Federal de Sa˜o Paulo, R. Botucatu 862, 04023-900 Sa˜o Paulo, SP, Brazil d Instituto de Cieˆncias Biolo´gicas e Naturais, UFTM, Av. Frei Paulino 30, 38025-180 Uberaba, MG, Brazil Received 15 March 2012; accepted 16 July 2012 Available online 27 July 2012 Abstract Recognizing the invasive potential of the dermatophytes and understanding the mechanisms involved in this process will help with disease diagnosis and with developing an appropriate treatment plan. In this report, we present the histopathological, microbiological and immunological features of a model of invasive dermatophytosis that is induced by subcutaneous infection of Trichophyton mentagrophytes in healthy adult Swiss mice. Using this model, we observed that the fungus rapidly spreads to the popliteal lymph nodes, spleen, liver and kidneys. Similar to the human disease, the lymph nodes were the most severely affected sites.
    [Show full text]
  • Case Report: Nosocomial Fungemia Caused by Candida Diddensiae Seong Eun Kim1, Sook in Jung1* , Kyung-Hwa Park1, Yong Jun Choi2, Eun Jeong Won2 and Jong Hee Shin2
    Kim et al. BMC Infectious Diseases (2020) 20:377 https://doi.org/10.1186/s12879-020-05095-3 CASE REPORT Open Access Case report: nosocomial fungemia caused by Candida diddensiae Seong Eun Kim1, Sook In Jung1* , Kyung-Hwa Park1, Yong Jun Choi2, Eun Jeong Won2 and Jong Hee Shin2 Abstract Background: Candida diddensiae, a yeast found in olive oil, is considered non-pathogenic to humans. Here, we describe the first case of fungemia caused by C. diddensiae in a hospitalized patient with underlying diseases. Case presentation: A 62-year-old woman was admitted because of multiple contusions due to repeated falls and generalized weakness. She presented with chronic leukopenia due to systemic lupus erythematosus, and multiple cranial nerve neuropathies due to a recurring chordoma. She was given a lipid emulsion containing total parenteral nutrition (TPN) starting on the day of admission. Broad-spectrum antibiotics had been administered during her last hospital stay and from day 8 of this hospitalization. However, no central venous catheter was used during this hospital stay. Blood cultures obtained on hospital days 17, 23, and 24 yielded the same yeast, which was identified as C. diddensiae via sequence analyses of the internal transcribed spacer region and D1/D2 regions of the 26S ribosomal DNA of the rRNA gene. In vitro susceptibility testing showed that the minimum inhibitory concentration of fluconazole for all isolates was 8 μg/mL. On day 23, TPN was discontinued and fluconazole therapy was started. Blood cultures obtained on day 26 were negative. The fluconazole therapy was replaced with micafungin on day 26 and the patient exhibited improvements.
    [Show full text]
  • Glucocorticoids and Invasive Fungal Infections
    REVIEW Review Glucocorticoids and invasive fungal infections Michail S Lionakis and Dimitrios P Kontoyiannis Since the 1990s, opportunistic fungal infections have emerged as a substantial cause of morbidity and mortality in profoundly immunocompromised patients. Hypercortisolaemic patients, both those with endogenous Cushing’s syndrome and, much more frequently, those receiving exogenous glucocorticoid therapy, are especially at risk of such infections. This vulnerability is attributed to the complex dysregulation of immunity caused by glucocorticoids. We critically review the spectrum and presentation of invasive fungal infections that arise in the setting of hypercortisolism, and the ways in which glucocorticoids contribute to their pathogenesis. A better knowledge of the interplay between glucocorticoid-induced immunosuppression and invasive fungal infections should assist in earlier recognition and treatment of such infections. Efforts to decrease the intensity of glucocorticoid therapy should help to improve outcomes of opportunistic fungal infections. Introduction efficient phagocytic capacity, phagocytosing more than Cushing’s syndrome is a metabolic condition featuring 108 conidia daily.5 Still, some conidia escape phagocytosis, persistently excessive plasma cortisol levels (normal germinate to hyphae, and establish an invasive infection. morning values: 138–607 nmol/L). Its origins fall into two Then, neutrophils are chemotactically attracted and categories. First, endogenous Cushing’s syndrome is attach to the hyphae, which
    [Show full text]
  • Clinical and Etiological Study of Onychomycosis in Institutionalized
    ISSN: 2469-5858 Oliveira et al. J Geriatr Med Gerontol 2019, 5:062 DOI: 10.23937/2469-5858/1510062 Volume 5 | Issue 1 Journal of Open Access Geriatric Medicine and Gerontology ReSeARCH ARTiCLe Clinical and Etiological Study of Onychomycosis in Institutionalized Elderly in Goiânia City, Goiás State, Brazil Jefferson Teixeira Oliveira1, Mateus Silva Santos2, Wesley Vieira Naves3, Hygor Lima Costa1, Andressa Santana Santos4, Vivianny Aparecida Queiroz Freitas4, Maria do Rosário Rodrigues Silva4, Milton Camplesi Junior1, Antonio Márcio Teodoro Cordeiro Silva1 and Fábio Silvestre Ataides1* 1Institute of Health Sciences, University Paulista Campus Flamboyant, Brazil 2Postgraduate Program in Genetic, MGene, Pontifical Catholic University of Goiás, Brazil Check for 3Postgraduate Program in Environmental Sciences and Health, Pontifical Catholic University of Goiás, Brazil updates 4Postgraduate Program in Tropical Medicine and Public Health, Federal University of Goiás, Brazil *Corresponding author: Prof Dr. Fábio Silvestre Ataides, Institute of Health Sciences, University Paulista Campus Flam- boyant, Rua Beijuaçu Q.168, Lt.14, Setor Parque Amazonas, Goiânia, Goiás, Brazil, CEP: 74835-340, Tel: 55-62-99631- 8545 Abstract Conclusions: This study found a higher frequency of onychomycosis in women, and the main etiological agents Background: Onychomycosis is fungal nail infection, which were Candida spp. and Fusarium spp. The onychomycosis can be associated with some factors, such as decreased significantly changes the routine of its patients, with most nail growth and immunodeficiency, makes the elderly participants reporting that people find it unpleasant to look at predisposed to onychomycosis. The objective of this study their nails and note the problem and they are uncomfortable was to investigate the frequency of onychomycosis in elderly with the appearance of the lesion.
    [Show full text]
  • Pathology of Fungal Infection
    14/10/56 Pathology of Fungal Infection Julintorn Somran, MD. Growth form of fungi Filamentous or hyphae Yeasts 1 14/10/56 Dimorphic fungi • Presence of both filamentous forms and yeasts in their cycle – Histoplasma spp. • Hyphae at environmental temperatures and yeast form in the body – Candida spp. • Hyphae, pseudohyphae, and yeast form in the body Three types of fungal infection (Mycoses) 1. Superficial mycoses: – Skin, hair, and nails 2. Cutaneous and Subcutaneous mycoses: – deeper layer of skin 3. Systemic or deep mycoses: – internal organ involvement – Including opportunistic infection 2 14/10/56 Superficial mycoses Tinea (Ringworm) Ptyriasis versicolor Cutaneous and Subcutaneous mycoses Eumycotic mycetoma 3 14/10/56 Systemic or deep mycoses Mucormycosis or Zygomycosis Systemic or deep mycoses Pulmonary aspergilllosis 4 14/10/56 Host – Agent relationship Immunocompetent Nosocomial host infection Pathogenic agents Environment Organisms Host Infectious disease Impaired Defense mechanism Immunocompromise Opportunistic host infection Superficial mycoses Representative Causative Growth form disease organisms in Tissue Dermatophytosis Microsporum, Filamentous form Trichophyton, and Epidermophyton Pityriasis versicolor or Malassezia Yeast and filamentous skin infection via form malassezia Tinea nigra or Exophialia Filamentous form keratomycosis nigrican (Phaeoanellomyces) (pigmented) palmaris wernekii Onychomycosis Microsporum, Filamentous form Trichophyton, Epidermophyton etc. 5 14/10/56 DERMATOPHYTOSIS • Definition and Epidemiology: – Common superficial infection caused by fungi that able to invade keratinized tissue – stratum corneum, hair, and nails. – World wide in distribution – The source of infection – another person, animal or soil • Etiologic agents: – Microsporum, Trichophyton, and Epidermophyton – T rubrum – most common for tinea pedis and onychomycosis in temperate climate, and tinea cruris and tinea corporis in the tropics.
    [Show full text]
  • Update on Respiratory Fungal Infections in Cystic Fibrosis Lung Disease and After Lung Transplantation
    Journal of Fungi Review Update on Respiratory Fungal Infections in Cystic Fibrosis Lung Disease and after Lung Transplantation Sabine Renner 1, Edith Nachbaur 1, Peter Jaksch 2 and Eleonora Dehlink 1,* 1 Division of Pediatric Pulmonology, Allergology and Endocrinology, Department of Pediatrics and Adolescent Medicine, Associated National Center in the European Reference Network on Rare Respiratory Diseases ERN-LUNG and the European Reference Network on Transplantation in Children, ERN TRANSPLANT-CHILD, Medical University of Vienna, 1090 Vienna, Austria; [email protected] (S.R.); [email protected] (E.N.) 2 Division of Thoracic Surgery, Medical University of Vienna, 1090 Vienna, Austria; [email protected] * Correspondence: [email protected] Received: 10 November 2020; Accepted: 16 December 2020; Published: 21 December 2020 Abstract: Cystic fibrosis is the most common autosomal-recessive metabolic disease in the Western world. Impaired trans-membrane chloride transport via the cystic fibrosis transmembrane conductance regulator (CFTR) protein causes thickened body fluids. In the respiratory system, this leads to chronic suppurative cough and recurrent pulmonary infective exacerbations, resulting in progressive lung damage and respiratory failure. Whilst the impact of bacterial infections on CF lung disease has long been recognized, our understanding of pulmonary mycosis is less clear. The range and detection rates of fungal taxa isolated from CF airway samples are expanding, however,
    [Show full text]